# | Title | Journal | Year | Citations |
---|
1 | Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme | Journal of Neuro-Oncology | 2011 | 1,107 |
2 | Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies | Journal of Neuro-Oncology | 2013 | 1,054 |
3 | Epidemiology and etiology of meningioma | Journal of Neuro-Oncology | 2010 | 866 |
4 | Brain metastases: epidemiology and pathophysiology | Journal of Neuro-Oncology | 2005 | 816 |
5 | Intracranial Thermotherapy using Magnetic Nanoparticles Combined with External Beam Radiotherapy: Results of a Feasibility Study on Patients with Glioblastoma Multiforme | Journal of Neuro-Oncology | 2007 | 632 |
6 | Glioblastoma survival in the United States before and during the temozolomide era | Journal of Neuro-Oncology | 2012 | 632 |
7 | Molecular Mechanisms of Glioma Cell Migration and Invasion | Journal of Neuro-Oncology | 2004 | 476 |
8 | The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline | Journal of Neuro-Oncology | 2010 | 446 |
9 | The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma | Journal of Neuro-Oncology | 2006 | 409 |
10 | The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline | Journal of Neuro-Oncology | 2010 | 361 |
11 | Recent advances in the molecular understanding of glioblastoma | Journal of Neuro-Oncology | 2012 | 358 |
12 | Pathological classification and molecular genetics of meningiomas | Journal of Neuro-Oncology | 2010 | 355 |
13 | Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas | Journal of Neuro-Oncology | 2009 | 353 |
14 | The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: Results of a randomized trial | Journal of Neuro-Oncology | 1989 | 348 |
15 | Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients | Journal of Neuro-Oncology | 2005 | 335 |
16 | Improved survival time trends for glioblastoma using the SEER 17 population-based registries | Journal of Neuro-Oncology | 2012 | 332 |
17 | Maximizing safe resection of low- and high-grade glioma | Journal of Neuro-Oncology | 2016 | 330 |
18 | Microsurgery plus whole brain irradiation versus Gamma Knife surgery alone for treatment of single metastases to the brain: a randomized controlled multicentre phase III trial | Journal of Neuro-Oncology | 2008 | 328 |
19 | Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma | Journal of Neuro-Oncology | 2007 | 316 |
20 | Brain tumor survival: results from the National Cancer Data Base | Journal of Neuro-Oncology | 1998 | 314 |
21 | Epidemiology and etiology of intracranial meningiomas: A review | Journal of Neuro-Oncology | 1996 | 311 |
22 | Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues | Journal of Neuro-Oncology | 2002 | 305 |
23 | Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression | Journal of Neuro-Oncology | 2007 | 300 |
24 | Leptomeningeal metastases: Comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemias | Journal of Neuro-Oncology | 1990 | 290 |
25 | Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy | Journal of Neuro-Oncology | 2000 | 289 |
26 | WHO grade II and III meningiomas: a study of prognostic factors | Journal of Neuro-Oncology | 2009 | 284 |
27 | The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline | Journal of Neuro-Oncology | 2010 | 283 |
28 | Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy | Journal of Neuro-Oncology | 2012 | 280 |
29 | Molecular markers in glioma | Journal of Neuro-Oncology | 2017 | 279 |
30 | The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline | Journal of Neuro-Oncology | 2010 | 277 |
31 | Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas | Journal of Neuro-Oncology | 2003 | 274 |
32 | Diagnostic accuracy of MRI compared to CCT in patients with brain metastases | Journal of Neuro-Oncology | 1999 | 266 |
33 | Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan | Journal of Neuro-Oncology | 2009 | 264 |
34 | Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target | Journal of Neuro-Oncology | 2009 | 255 |
35 | Molecular pathogenesis of meningiomas | Journal of Neuro-Oncology | 2004 | 252 |
36 | Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma | Journal of Neuro-Oncology | 2000 | 251 |
37 | Prediction of pathology and survival by FDG PET in gliomas | Journal of Neuro-Oncology | 2003 | 251 |
38 | Descriptive epidemiology of primary spinal cord tumors | Journal of Neuro-Oncology | 2008 | 246 |
39 | Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma | Journal of Neuro-Oncology | 2013 | 246 |
40 | Endoscopic transsphenoidal surgery | Journal of Neuro-Oncology | 2001 | 244 |
41 | Malignant meningioma: an indication for initial aggressive surgery and adjuvant radiotherapy | Journal of Neuro-Oncology | 1998 | 239 |
42 | Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta | Journal of Neuro-Oncology | 2001 | 231 |
43 | Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma | Journal of Neuro-Oncology | 2008 | 230 |
44 | New concepts in surgery of WHO grade II gliomas: functional brain mapping, connectionism and plasticity – a review | Journal of Neuro-Oncology | 2006 | 228 |
45 | Prognostic significance of preoperative MRI scans in glioblastoma multiforme | Journal of Neuro-Oncology | 1996 | 227 |
46 | Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases | Journal of Neuro-Oncology | 2015 | 224 |
47 | Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-alpha and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment of malignant brain tumors | Journal of Neuro-Oncology | 2003 | 222 |
48 | Spheroid Preparation from Hanging Drops: Characterization of a Model of Brain Tumor Invasion | Journal of Neuro-Oncology | 2004 | 222 |
49 | miR-21 and 221 upregulation and miR-181b downregulation in human grade II–IV astrocytic tumors | Journal of Neuro-Oncology | 2009 | 211 |
50 | Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT) | Journal of Neuro-Oncology | 2006 | 210 |